Catalyst Wire Dossier Catalyst Wire Dossier

Aticaprant

Aticaprant · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Aticaprant, covering 2025-04-27 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure [Phase 3]

See pricing